The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023
The company has secured 506 marketing approvals for its oncology products across 76 countries.
The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
The product basket increased to 1800 medicines and 285 Surgical Equipment
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Subscribe To Our Newsletter & Stay Updated
